The Cefazolin Inoculum Effect Is Associated With Increased Mortality in Methicillin-Susceptible Staphylococcus aureus Bacteremia
Author(s) -
William R. Miller,
Carlos Seas,
Lina P Carvajal,
Lorena Díaz,
Aura M Echeverri,
Carolina Ferro,
Rafael Ríos,
Paola Porras,
Carlos M. Luna,
Eduardo Gotuzzo,
José M. Munita,
Esteban C. Nannini,
Cesar Cárcamo,
Jinnethe Reyes,
César A. Arias
Publication year - 2018
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofy123
Subject(s) - cefazolin , bacteremia , medicine , staphylococcus aureus , cephalosporin , endocarditis , nafcillin , staphylococcal infections , confidence interval , antibiotics , microbiology and biotechnology , penicillin , biology , bacteria , genetics
In patients with MSSA bacteremia where cephalosporins are used as firstline therapy, the CzIE was associated with increased 30-day mortality. Clinicians should be cautious when using cefazolin as firstline therapy for these infections.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom